T. Rowe Price Associates »

Inhibrx Biosciences shares owned by T. Rowe Price Associates

Quarter-by-quarter ownership of Inhibrx Biosciences (INBX) shares owned by T. Rowe Price Associates from 13F filings

Historical chart of T. Rowe Price Associates investment in Inhibrx Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Inhibrx Biosciences held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inhibrx Biosciences by T. Rowe Price Associates

Quarter filed Position value Share count Share price at filing
2026-03-31 $472k 7.0k 67.31
2025-12-31 $422k 5.3k 79.12

More positions owned by T. Rowe Price Associates

Nvidia Corporation Comm Stk (NVDA)
Apple Comm Stk (AAPL)
Microsoft Corp Comm Stk (MSFT)
Broadcom Comm Stk (AVGO)
Amazon Comm Stk (AMZN)
Alphabet Comm Stk (GOOGL)
Alphabet Comm Stk (GOOG)
Meta Platforms Comm Stk (META)
Eli Lilly & Co Comm Stk (LLY)
Visa Comm Stk (V)
Netflix Comm Stk (NFLX)
Mastercard Incorporated Comm Stk (MA)
Tesla Comm Stk (TSLA)
Jpmorgan Chase & Co Comm Stk (JPM)
Ge Aerospace Comm Stk (GE)

View all positions for T. Rowe Price Associates

Top funds holding Inhibrx Biosciences

Perceptive Advisors
Viking Global Investors
Morgan Stanley
Sanofi
HighTower Advisors
BlackRock
State Street Corporation
Vanguard Capital Management
Sofinnova Ventures
Capital Research Global Investors
Woodline Partners
Millennium Management
Partner Fund Management
Schonfeld Strategic Advisors
Geode Capital Management

View all funds holding Inhibrx Biosciences